Vascular endothelial growth factor pathway.
Maitland
Michael L
ML
Department of Medicine, Section of Hematology/Oncology, University of Chicago, Maryland Avenue, Chicago, Illinois, USA.
Lou
Xing Jian
XJ
Ramirez
Jacqueline
J
Desai
Apurva A
AA
Berlin
Dorit S
DS
McLeod
Howard L
HL
Weichselbaum
Ralph R
RR
Ratain
Mark J
MJ
Altman
Russ B
RB
Klein
Teri E
TE
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology; D000068258:Bevacizumab; D002986:Clinical Trials as Topic; D015972:Gene Expression Regulation, Neoplastic; D005838:Genotype; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D010597:Pharmacogenetics; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab